Noninvasive assessment of left ventricular remodeling: Concepts, techniques, and implications for clinical trials

Journal of Cardiac Failure

Volumn 8, Issue 6 SUPPL., 2002, Pages

  Anand, Inder S ^a,d   Florea, Viorel G ^a   Solomon, Scott D ^b   Konstam, Marvin A ^b   Udelson, James E ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Accuracy; Echocardiography; Magnetic resonance imaging; Radionuclide ventriculography; Reproducibility

Indexed keywords

ANGIOGRAPHY; CONFERENCE PAPER; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; IMAGING; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; REPRODUCIBILITY;

EID: 0036951697     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2002.129286     Document Type: Conference Paper

References (86)

1. Schocken DD, Arrieta MI, Leaverton PE, Ross EA: Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-306
2. From the Centers for Disease Control and Prevention: Mortality from congestive heart failure - United States, 1980-1990. JAMA 1994;271:813-814
3. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ: Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51
4. Dunn FG, Pringle SD: Sudden cardiac death, ventricular arrhythmias and hypertensive left ventricular hypertrophy. J Hypertens 1993;11:1003-1010
5. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566
6. Pollick C, Fitzgerald PJ, Popp RL: Variability of digitized echocardiography: Size, source, and means of reduction. Am J Cardiol 1983;51:576-582
7. Gordon EP, Schnittger I, Fitzgerald PJ, Williams P, Popp RL: Reproducibility of left ventricular volumes by two-dimensional echocardiography. J Am Coll Cardiol 1983;2:506-513
8. Florea VG, Henein MY, Anker SD, Francis DP, Gibson DG, Coats AJ: Relation of changes over time in ventricular size and function to those in exercise capacity in patients with chronic heart failure. Am Heart J 2000;139:913-917
9. Katz J, Milliken MC, Stray-Gundersen J, et al: Estimation of human myocardial mass with MR imaging. Radiology 1988;169:495-498
10. Rehr RB, Malloy CR, Filipchuk NG, Peshock RM: Left ventricular volumes measured by MR imaging, Radiology 1985;156:717-719
11. McDonald KM, Parrish T, Wennberg P, Stillman AE, Francis GS, Cohn JN, Hunter D: Rapid, accurate and simultaneous noninvasive assessment of right and left ventricular mass with nuclear magnetic resonance imaging using the snapshot gradient method. J Am Coll Cardiol 1992;19:1601-1607
12. Caputo GR, Tscholakoff D, Sechtem U, Higgins CB: Measurement of canine left ventricular mass by using MR imaging. Am J Roentgenol 1987;148:33-38
13. Shapiro EP, Rogers WJ, Beyar R, Soulen RL, Zerhouni EA, Lima JA, Weiss JL: Determination of left ventricular mass by magnetic resonance imaging in hearts deformed by acute infarction. Circulation 1989;79:706-711
14. Reichek N, Helak J, Plappert T, Sutton MS, Weber KT: Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: Initial results. Circulation 1983;67:348-352
15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-458
16. Schapira JN, Kohn MS, Beaver WL, Popp RL: In vitro quantitation of canine left ventricular volume by phasedarray sector scan. Cardiology 1981;67:1-11
17. Kasprzak JD, Paelinck B, Ten Cate FJ, Vletter WB, de Jong N, Poldermans D, Elhendy A, Bouakaz A, Roelandt JR: Comparison of native and contrast-enhanced harmonic echocardiography for visualization of left ventricular endocardial border. Am J Cardiol 1999;83:211-217
18. Mulvagh SL, DeMaria AN, Feinstein SB, Burns PN, Kaul S, Miller JG, Monaghan M, Porter TR, Shaw LJ, Villanueva FS: Contrast echocardiography: Current and future applications. J Am Soc Echocardiogr 2000;13:331-342
19. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S: Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994;89:68-75
20. Kober L, Torp-Pedersen C, Carlsen J, Videbaek R, Egeblad H: An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation. Eur Heart J 1994;15:1616-1620
21. Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA: Left ventricular remodeling in the year after first anterior myocardial infarction: A quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol 1992;19:1136-1144
22. Collins HW, Kronenberg MW, Byrd BF: Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography. J Am Coll Cardiol 1989;14:672-676
23. Crawford MH, Grant D, O'Rourke RA, Starling MR, Groves BM: Accuracy and reproducibility of new M-mode echocardiographic recommendations for measuring left ventricular dimensions. Circulation 1980;61:137-143
24. Himelman RB, Cassidy MM, Landzberg JS, Schiller NB: Reproducibility of quantitative two-dimensional echocardiography. Am Heart J 1988;115:425-431
25. Pietro DA, Voelkel AG, Ray BJ, Parisi AF: Reproducibility of echocardiography. A study evaluating the variability of serial echocardiographic measurements. Chest 1981;79:29-32
26. Devereux RB, Hammond IW, Lutas EM, Spitzer MC, Alderman MH, Laragh JH: Year-to-year variability of echocardiographic measurements in normal subjects. J Am Coll Cardiol 1984;3:516A
27. Reichek N: Standardization in the measurement of left ventricular wall mass. Two-dimensional echocardiography. Hypertension 1987;9:II30-II32
28. Aikawa Y, Rohde L, Plehn J, Greaves SC, Menapace F, Arnold MO, Rouleau JL, Pfeffer MA, Lee RT, Solomon SD: Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): An echocardiography-based structural analysis. Am Heart J 2001;141:234-242
29. Oldroyd KG, Pye MP, Ray SG, Christie J, Ford I, Cobbe SM, Dargie HJ: Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol 1991;68:713-718
30. Gaudron P, Eilles C, Kugler I, Ertl G: Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993;87:755-763
31. Pfeffer MA, Greaves SC, Arnold JM, Glynn RJ, LaMotte FS, Lee RT, Menapace FJ, Jr, Rapaport E, Ridker PM, Rouleau JL, Solomon SD, Hennekens CH: Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation 1997;95:2643-2651
32. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302
33. Kober L, Torp-Pedersen C, Carlsen JE, Baggar H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC: A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995;333:1670-1676
34. Solomon SD, Glynn RJ, Greaves S, Ajani U, Rouleau JL, Menapace F, Arnold JM, Hennekens C, Pfeffer MA: Recovery of ventricular function after myocardial infarction in the reperfusion era: The healing and early afterload reducing therapy study. Ann Intern Med 2001;134:451-458
35. Konstam MA, Wynne J, Holman BL, Brown EJ, Neill JM, Kozlowski J: Use of equilibrium (gated) radionuclide ventriculography to quantitate left ventricular output in patients with and without left-sided valvular regurgitation. Circulation 1981;64:578-585
36. Upton MT, Rerych SK, Newman GE, Bounous EP Jr, Jones RH: The reproducibility of radionuclide angiographic measurements of left ventricular function in normal subject at rest and during exercise. Circulation 1980;62:126-132
37. Marshall RC, Berger HJ, Reduto LA, Gottschalk A, Zaret BL: Variability in sequential measures of left ventricular performance assessed with radionuclide angiocardiography. Am J Cardiol 1978;41:531-536
38. Cohn PF, Levine JA, Bergeron GA, Gorlin R: Reproducibility of the angiographic left ventricular ejection fraction in patients with coronary artery disease. Am Heart J 1974;88:713-720
39. Chaitman BR, DeMots H, Bristow JD, Rosch J, Rahimtoola SH: Objective and subjective analysis of left ventricular angiograms. Circulation 1975;52:420-425
40. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, et al: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 1992;86:431-438
41. van Royen N, Jaffe CC, Krumholz HM, Johnson KM, Lynch PJ, Natale D, Atkinson P, Deman P, Wackers FJ: Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol 1996;77:843-850
42. Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, et al: Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation 1993;88:2277-2283
43. vanSonnenberg E, Neff CC, Pfister RC: Life-threatening hypotensive reactions to contrast media administration: Comparison of pharmacologic and fluid therapy. Radiology 1987;162:15-19
44. Katzberg RW: Renal effects of contrast media. Invest Radiol 1988;23(suppl 1):S157-S160
45. Longmore DB, Klipstein RH, Underwood SR, Firmin DN, Hounsfield GN, Watanabe M, Bland C, Fox K, Poole-Wilson PA, Rees RS, et al: Dimensional accuracy of magnetic resonance in studies of the heart. Lancet 1985;1:1360-1362
46. Sechtem U, Pflugfelder PW, Gould RG, Cassidy MM, Higgins CB: Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology 1987;163:697-702
47. Utz JA, Herfkens RJ, Heinsimer JA, Bashore T, Califf R, Glover G, Pelc N, Shimakawa A: Cine MR determination of left ventricular ejection fraction. Am J Roentgenol 1987;148:839-843
48. Van Rossum AC, Visser FC, Sprenger M, Van Eenige MJ, Valk J, Roos JP: Evaluation of magnetic resonance imaging for determination of left ventricular ejection fraction and comparison with angiography. Am J Cardiol 1988;62:628-633
49. Cranney GB, Lotan CS, Dean L, Baxley W, Bouchard A, Pohost GM: Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validation by calibrated ventricular angiography. Circulation 1990;82:154-163
50. Rogers WJ Jr, Shapiro EP, Weiss JL, Buchalter MB, Rademakers FE, Weisfeldt ML, Zerhouni EA: Quantification of an correction for left ventricular systolic long-axis shortening by magnetic resonance tissue tagging and slice isolation. Circulation 1991;84:721-731
51. Axel L, Dougherty L: MR imaging of motion with spatial modulation of magnetization. Radiology 1989;171:841-845
52. Power TP, Kramer CM, Shaffer AL, Theobald TM, Petruolo S, Reichek N, Rogers WJ Jr.: Breath-hold dobutamine magnetic resonance myocardial tagging: Normal left ventricular response. Am J Cardiol 1997;80:1203-1207
53. Geskin G, Kramer CM, Rogers WJ, Theobald TM, Pakstis D, Hu YL, Reichek N: Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 1998;98:217-223
54. Kramer CM, Lima JA, Reichek N, Ferrari VA, Llaneras MR, Palmon LC, Yeh IT, Tallant B, Axel L: Regional differences in function within noninfarcted myocardium during left ventricular remodeling. Circulation 1993;88:1279-1288
55. Bellenger NG, Gatehouse PD, Rajappan K, Keegan J, Firmin DN, Pennell DJ: Left ventricular quantification in heart failure by cardiovascular MR using prospective respiratory navigator gating: Comparison with breath-hold acquisition. J Magn Reson Imaging 2000;11:411-417
56. Epstein FH, Wolff SD, Arai AE: Segmented k-space fast cardiac imaging using an echo-train readout. Magn Reson Med 1999;41:609-613
57. Nagel E, Schneider U, Schalla S: Magnetic resonance real-time imaging for the evaluation of left ventricular function. J Cardiovasc Magn Reson 2000;2:7-14
58. Yang PC, Kerr AB, Liu AC, Liang DH, Hardy C, Meyer CH, Macovski A, Pauly JM, Hu BS: New real-time interactive cardiac magnetic resonance imaging system complements echocardiography. J Am Coll Cardiol 1998;32:2049-2056
59. Gimbel JR, Johnson D, Levine PA, Wilkoff BL: Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 1996;19:913-919
60. Balzer P, Furber A, Cavaro-Menard C, Croue A, Tadei A, Geslin P, Jallett P, Le Jeune JJ: Simultaneous and correlated detection of endocardial and epicardial borders on short-axis MR images for the measurement of left ventricular mass. Radiographics 1998;18:1009-1018
61. Nachtomy E, Cooperstein R, Vaturi M, Bosak E, Vered Z, Akselrod S: Automatic assessment of cardiac function from short-axis MRI: Procedure and clinical evaluation. Magn Reson Imaging 1998;16:365-376
62. Eichstadt HW, Felix R, Langer M, Gutmann ML, Dougherty FC, Huben HJ, Schmutzler H: Use of nuclear magnetic resonance imaging to show regression of hypertrophy with ramipril treatment. Am J Cardiol 1987;59:98D-103D
63. Bellenger NG, Davies LC, Francis JM, Marcus NJ, Pennell DJ: Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000;2(In press)
64. Mogelvang J, Stokholm KH, Saunamaki K, Reimer A, Stubgaard M, Thomsen C, Fritz-Hansen P, Henriksen O: Assessment of left ventricular volumes by magnetic resonance in comparison with radionuclide angiography, contrast angiography and echocardiography. Eur Heart J 1992;13:1677-1683
65. Higgins CB: Which standard has the gold? J Am Coll Cardiol 1992;19:1608-1609
66. Pattynama PM, Lamb HJ, van der Velde EA, van der Wall EE, de Roos A: Left ventricular measurements with cine and spin-echo MR imaging: A study of reproducibility with variance component analysis. Radiology 1993;187:261-268
67. Semelka RC, Tomei E, Wagner S, Mayo J, Kondo C, Suzuki J, Caputo GR, Higgins CB: Normal left ventricular dimensions and function: Interstudy reproducibility of measurements with cine MR imaging. Radiology 1990;174:763-768
68. Semelka RC, Tomei E, Wagner S, Mayo J, Caputo G, O'Sullivan M, Parmley WW, Chatterjee K, Wolfe C, Higgins CB: Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J 1990;119:1367-1373
69. Debatin JF, Nadel SN. Paolini JF, Sostman HD, Coleman RE, Evans AJ, Beam C, Spritzer CE, Bashore TM: Cardiac ejection fraction: Phantom study comparing cine MR imaging, radionuclide blood pool imaging, and ventriculography. J Magn Reson Imaging 1992;2:135-142
70. Germain P, Roul G, Kastler B, Mossard JM, Bareiss P, Sacrez A: Inter-study variability in left ventricular mass measurement. Comparison between M-mode echography and MRI. Eur Heart J 1992;13:1011-1019
71. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90:29-34, 2002
72. Bottini PB, Carr AA, Prisant LM, Flickinger FW, Allison JD, Gottdiener JS: Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 1995;8:221-228
73. Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HB, Hildebrandt PR: Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 2000;36:2072-2080
74. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure Group: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007
75. Cohn JN, Tognoni G, Glazer RD, Spormann D, Hester A: Rationale and design of the Valsartan Heart Failure Trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. J Card Fail 1999;5:155-160
76. The BEST Steering Committee: Design of the Beta-Blocker Evaluation Survival Trial (BEST). Am J Cardiol 1995;75:1220-1223
77. Luscher TF, Ruschitzka F, Anand I, Konstam MA, McMurray J, Notter T, Cohn J, on behalf of the EARTH investigators: EARTH: EndothelinA Receptor Antagonist Trial in Heart Failure. Heart Drug 2001;1:294-298
78. Weiss JL, Shapiro EP, Buchalter MB, Beyar R: Magnetic resonance imaging as a noninvasive standard for the quantitative evaluation of left ventricular mass, ischemia, and infarction. Ann N Y Acad Sci 1990;601:95-106
79. Aurigemma G, Davidoff A, Silver K, Boehmer J: Left ventricular mass quantitation using single-phase cardiac magnetic resonance imaging. Am J Cardiol 1992;70:259-262
80. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, Shelton B: Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 1995;91:2573-2581
81. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691
82. Rousseau MF, Konstam MA, Benedict CR, Donckier J, Galanti L, Melin J, Kinan D, Ahn S, Ketelslegers JM, Pouleur H: Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor. Am J Cardiol 1994;73:488-493
83. Hampton JR, van Veldhuisen DJ, Kleber FX, Cowley AJ, Ardia A, Block P, Cortina A, Cserhalmi L, Follath F, Jensen G, Kayanakis J, Lie KI, Mancia G, Skene AM: Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators. Lancet 1997;349:971-974
84. Konstam MA, Patten RD, Thomas I, Ramahi T, La Bresh K, Goldman S, Lewis W, Gradman A, Self KS, Bittner V, Rand W, Kinan D, Smith JJ, Ford T, Segal R, Udelson JE: Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: Results of the ELITE ventricular function substudy. Am Heart J 2000;139:1081-1087
85. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II. Lancet 2000;355:1582-1587
86. Rouleau JL, Pfeffer MA, Stewart DJ, Isaac D, Sestier F, Kerut EK, Porter CB, Proulx G, Qian C, Block AJ: Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet 2000;356:615-620